Skip to main content
Livermore
Livermore
ZHEN

TD Private Client Wealth LLC

SEC CIK
0001551017
Latest filing
Aug 4, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by TD Private Client Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
150
Value
$93.5K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of REGN by TD Private Client Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026150$93.5K<0.1%−20−11.8%ReducedHolders
Q1 2026170$131.3K<0.1%+1+0.6%AddedHolders
Q4 2025169$130.4K<0.1%+15+9.7%AddedHolders
Q3 2025154$86.6K<0.1%+46+42.6%AddedHolders
Q2 2025108$56.7K<0.1%−19−15.0%ReducedHolders
Q1 2025127$80.5K<0.1%−44−25.7%ReducedHolders
Q4 2024171$121.8K<0.1%+15+9.6%AddedHolders
Q3 2024156$164.0K<0.1%+7+4.7%AddedHolders
Q2 2024149$156.6K<0.1%−8−5.1%ReducedHolders
Q1 2024157$151.1K<0.1%+20+14.6%AddedHolders
Q4 2023137$120.3K<0.1%+5+3.8%AddedHolders
Q3 2023132$108.6K<0.1%−4−2.9%ReducedHolders
Q2 2023136$97.7K<0.1%−10−6.8%ReducedHolders
Q1 2023146$120.0K<0.1%+4+2.8%AddedHolders
Q4 2022142$102.5K<0.1%−7−4.7%ReducedHolders
Q3 2022149$102.6K<0.1%+33+28.4%AddedHolders
Q2 2022116$68.6K<0.1%−41−26.1%ReducedHolders
Q1 2022157$109.7K<0.1%+23+17.2%AddedHolders
Q4 2021134$84.6K<0.1%+38+39.6%AddedHolders
Q3 202196$58.1K<0.1%−186−66.0%ReducedHolders
Q2 2021282$157.5K<0.1%+32+12.8%AddedHolders
Q1 2021250$118.3K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.